Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
News-Medical.Net on MSN
Researchers develop a versatile tool for controlling gene activity
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...
Here’s the latest company planning for gene-edited babies The news: A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...
Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, including 12 oral presentations, from its industry-leading hematology portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback